Order results by:
| Issue | Title | |
| Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
| E. EL. Trisvetova | ||
| "... . Lercanidipine is a dihydropyridine calcium channel blocker of the third generation with high lipophilicity ..." | ||
| Vol 10, No 3 (2014) | OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE | Abstract similar documents |
| E. L. Trisvetova | ||
| "... to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine ..." | ||
| Vol 12, No 6 (2016) | RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME | Abstract similar documents |
| O. M. Drapkina, J. S. Sibgatullina | ||
| Vol 13, No 3 (2017) | HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
| O. A. Kislyak, A. V. Starodubova, A. A. Kopelev | ||
| "... of using the last generation of calcium channel blockers in this clinical situation with an emphasis ..." | ||
| Vol 11, No 5 (2015) | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation | Abstract similar documents |
| E. I. Emelina, G. E. Gendlin | ||
| "... Features and possibility of application of the calcium channel blocker lercanidipine in cardiology ..." | ||
| Vol 9, No 1 (2013) | LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov | ||
| "... Classification, modes of action and clinical effects of calcium channel blockers are presented ..." | ||
| Vol 6, No 4 (2010) | POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... and safety of the modern calcium channel blocker (CCB), lercanidipine, are presented. Results of these trials ..." | ||
| Vol 10, No 1 (2014) | TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS | Abstract similar documents |
| A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta | ||
| "... for the combination of an ACE inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from ..." | ||
| Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchenov | ||
| "... and safety of the combination of calcium antagonist of the third generation, lercanidipine, and ACE inhibitor ..." | ||
| Vol 7, No 3 (2011) | EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY | similar documents |
| M. A. Ninci, R. Magliocca, A. Malliani | ||
| "... Цель. Оценить эффективность лерканидипина (антагониста кальция из группы дигидропиридинов) у ..." | ||
| Vol 20, No 3 (2024) | BRASH syndrome: а clinical case | Abstract similar documents |
| D. D. Shalaeva, K. G. Pereverzeva, O. A. Fomina, S. S. Yakushin | ||
| "... , lercanidipine hydrochloride daily. She was admitted to the hospital complaining of weakness, eyes darkening ..." | ||
| Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... lercanidipine and angiotensin-converting enzyme inhibitor enalapril. ..." | ||
| Vol 12, No 5 (2016) | Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine | Abstract similar documents |
| O. V. Zimnitskaya, M. M. Petrova | ||
| "... Aim. To study the effect of olmesartan/lercanidipine combination and zofenopril/lercanidipine ..." | ||
| Vol 4, No 2 (2008) | BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL | Abstract similar documents |
| A. N. Zakirova, F. S. Zarudij, B. N. Garifullin | ||
| "... Approaches evolution to studying of beta-blockers influence on platelet aggregation is reviewed ..." | ||
| Vol 4, No 4 (2008) | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST | Abstract similar documents |
| L. N. Malaj | ||
| "... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..." | ||
| Vol 7, No 2 (2011) | SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY | Abstract similar documents |
| E. V. Filippov, S. S. Yakushin | ||
| "... -blockers among all available drugs for SCD prevention. ..." | ||
| Vol 6, No 6 (2010) | THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS | Abstract similar documents |
| Yu. A. Bunin | ||
| "... and VA only beta-blockers and amiodarone are able to reduce mortality, while other drugs have no effect ..." | ||
| Vol 8, No 2 (2012) | TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... Data on angiotensin II receptor blockers, one of the main drug classes used in cardiology ..." | ||
| Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
| A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
| "... and various beta-blockers (atenolol, metoprolol, bisoprolol). These beta-blockers were changed for carvedilol ..." | ||
| Vol 10, No 6 (2014) | IRBESARTAN IN THE CLINICAL PRACTICE | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..." | ||
| Vol 9, No 6 (2013) | POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK | Abstract similar documents |
| Z M. Sizova | ||
| "... Current possibilities of AT1 receptor blockers (ARBs), such as candesartan, for optimization ..." | ||
| Vol 7, No 1 (2011) | TIMING OF PRE-OPERATIVE BETA-BLOCKER TREATMENT IN VASCULAR SURGERY PATIENTS: INFLUENCE ON POST-OPERATIVE OUTCOME | similar documents |
| W.-J. Flu, J.-P. van Kuijk, M. Chonchol, T. A. Winkel, H.J.M. Verhagen, J. J. Bax, D. Poldermans | ||
| "... Введение. В соответствии с мнением экспертов, рекомендуется начинать терапию β-блокаторами в сроки ..." | ||
| Vol 18, No 6 (2022) | The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation | Abstract similar documents |
| A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev | ||
| Vol 5, No 4 (2009) | BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES | Abstract similar documents |
| G. N. Gorokchovskaya, M. M. Petina | ||
| "... Beta-blockers application in modern cardiologic practice is reviewed with focus on beta-blocker ..." | ||
| Vol 7, No 2 (2011) | A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina | ||
| Vol 13, No 6 (2017) | FEATURES OF MANAGEMENT OF PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE: MODERN APPROACHES | Abstract similar documents |
| D. А. Napalkov, A. A. Sokolova | ||
| Vol 3, No 3 (2007) | COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich | ||
| Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
| "... received C 12,5 mg BID (Vedicardol, “Sintez”), another part – M 25 mg/day BID. Doubling dose of β-blockers ..." | ||
| Vol 4, No 5 (2008) | INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS | Abstract similar documents |
| V. V. Fomin | ||
| "... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..." | ||
| Vol 6, No 5 (2010) | EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY | Abstract similar documents |
| O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva | ||
| "... . To evaluate the efficacy and safety of beta-blocker bisoprolol in the perioperative period in hypertensive ..." | ||
| Vol 9, No 2 (2013) | A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE | Abstract similar documents |
| G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi | ||
| "... and Angiotensin Receptor Blockers in Patients Without Heart Failure» J Am Coll Cardiol 2013;61(2):131-42; http ..." | ||
| Vol 12, No 3 (2016) | PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, A. V. Zakharova, M. M. Loukianov, A. N. Vorobyev, K. A. Moseichuk, A. N. Kozminsky | ||
| "... Aim. To assess real clinical practice of prescribing beta-blockers (BB) and its compliance ..." | ||
| Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, M. V. Pisarev | ||
| "... blockers play in achieving target figures of blood pressure and reducing cardiovascular risk is discussed ..." | ||
| Vol 19, No 6 (2023) | Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible? | Abstract similar documents |
| V. D. Zakiev, N. M. Vorobyeva, I. P. Malaya, A. D. Gvozdeva, O. N. Tkacheva | ||
| "... use of beta-blockers in CHF patients with preserved LV EF in the absence of other indications for them ..." | ||
| Vol 6, No 2 (2010) | CLINICAL APPROACHES TO INTERPRETATION OF CLINICAL TRAILS RESULTS ON BETA-BLOCKERS FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| S. R. Giljarevskiy, I. M. Kuzmina | ||
| "... Modern approaches to a choice of beta-blockers for treatment of patients with chronic heart ..." | ||
| Vol 7, No 4 (2011) | COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) | Abstract similar documents |
| O. V. Dralova, M. L. Maksimov | ||
| Vol 7, No 4 (2011) | EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| E. I. Makhiyanova, A. S. Galyavich | ||
| "... Aim. To study of efficacy and safety of glycoprotein IIb/IIIa blocker monafram in acute ST ..." | ||
| Vol 14, No 1 (2018) | NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev | ||
| Vol 4, No 1 (2008) | EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
| S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY AND VASOPROTECTIVE PROPERTIES OF A NEW COMBINATION OF BETA-BLOCKER, BISOPROLOL (2,5/5 MG) AND DIURETIC, HYDROCHLOROTHIAZIDE (6,25 MG) | Abstract similar documents |
| O. D. Ostroumova, A. G. Sazonova, K. U. Reznikova, A. V. Srednjakov, E. A. Smolyarchuk | ||
| Vol 20, No 5 (2024) | The effect of the M235T polymorphism of the angiotensinogen gene on the office blood pressure during therapy with angiotensin II receptor blockers | Abstract similar documents |
| E. V. Rebrova, E. V. Shikh | ||
| "... receptor blockers in the form of monotherapy and as part of combination drugs in patients with hypertension ..." | ||
| Vol 13, No 2 (2017) | PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) | Abstract similar documents |
| M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov | ||
| "... converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) and β-blockers in the outpatient ..." | ||
| Vol 9, No 1 (2013) | MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina, B. B. Gegenava | ||
| Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
| "... -мононитрат пролонгированного действия) и бета-блокатора с вазодилатирующим действием (небиволол) — у больных ..." | ||
| Vol 9, No 5 (2013) | THE ASSESSMENT AND REDUCTION OF CARDIAC EVENTS RISK IN NONCARDIAC OPERATIONS: IS THERE A NEED FOR REVIEW OF RECOMMENDATIONS? | Abstract similar documents |
| A. N. Sumin | ||
| "... the available scientific evidence. In this review we discussed in detail the use of beta-blockers in noncardiac ..." | ||
| Vol 9, No 3 (2013) | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY | Abstract similar documents |
| S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik | ||
| "... correcting therapy including beta-oxidation blocker (meldonium) is discussed. ..." | ||
| Vol 11, No 4 (2015) | INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION | Abstract PDF (Eng) similar documents |
| K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev | ||
| Vol 20, No 4 (2024) | BRAНH syndrome: clinical case | Abstract similar documents |
| K. G. Pereverzeva, O. A. Fomina, Yu. S. Batishcheva, L. V. Filippov, S. S. Yakushin | ||
| "... , since against the background of taking an atrioventricular node blocker in a small dose, a patient ..." | ||
| Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... -Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure ..." | ||
| Vol 20, No 4 (2024) | The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years? | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... that none of these studies gave a positive result. A new study with beta-blockers, which proved its positive ..." | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... ; it is known that some angiotensin converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers ..." | ||
| Vol 16, No 4 (2020) | Felodipine in Treatment of Arterial Hypertension and Ischemic Heart Disease | Abstract similar documents |
| O. D. Ostroumova, I. A. Alautdinova, A. I. Kochetkov, S. N. Litvinova | ||
| "... ) and ischemic heart disease (IHD). Dihydropyridine calcium channel blockers (CCBs) are the first line ..." | ||
| Vol 3, No 1 (2007) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE | Abstract similar documents |
| S. Y. Martsevich | ||
| "... рандомизированных исследований, в которых изучалось влияние дигидропиридиновых антагонистов кальция на риск сердечно ..." | ||
| Vol 4, No 3 (2008) | ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The beta-blocker role in arterial hypertension treatment is surveyed from the positions of evidence ..." | ||
| Vol 4, No 2 (2008) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
| E. V. Shilova, S. Y. Martsevich | ||
| "... осложнений. Отмечается место дигидропиридиновых АК в современных рекомендациях по лечению артериальной ..." | ||
| Vol 6, No 2 (2010) | NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER | Abstract similar documents |
| T. Műnzel, T. Gori | ||
| "... . Nebivolol. The somewhat-different β-adrenergic receptor blocker was initially published in J Am Coll Cardiol ..." | ||
| Vol 11, No 1 (2015) | HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE | Abstract similar documents |
| S. V. Shalaev, L. V. Silicic, O. V. Abaturova | ||
| "... blocker ivabradine are discussed. The evidence-based data on ivabradine use reveal its advantages ..." | ||
| Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
| I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
| "... -blockers, the use of beta-adenoblocker with vasodilating activity, in particular carvedilol, makes ..." | ||
| Vol 12, No 1 (2016) | Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension) | Abstract PDF (Eng) similar documents |
| E. L. Trisvetova, S. V. Gubkin | ||
| "... , specific therapy with calcium channel blockers, prostacyclin analogues, endothelin receptor antagonists ..." | ||
| Vol 5, No 1 (2009) | ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The role of beta-blockers (BB) in arterial hypertension therapy is discussed from the evidence ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| Vol 16, No 5 (2020) | The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium | Abstract PDF (Eng) similar documents |
| O. A. Yepanchintseva, K. A. Mikhaliev, I. V. Shklianka, O. J. Zharinov, B. M. Todurov | ||
| "... system (RAS; 86.3%) blockers (angiotensin-converting enzyme inhibitors or angiotensin-II receptors ..." | ||
| Vol 13, No 4 (2017) | CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE | Abstract similar documents |
| O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva | ||
| "... The features of the pharmacokinetics of the angiotensin II receptor blocker telmisartan ..." | ||
| Vol 17, No 2 (2021) | Treatment of Resistant Hypertension in Real Clinical Settings | Abstract similar documents |
| A. S. Maltseva, A. E. Tsygankova, M. A. Gabitova, A. V. Rodionov, V. V. Fomin | ||
| "... ] blocker + calcium-channel blocker [CCB] + diuretic) plus one of the group of reserve drugs ..." | ||
| Vol 9, No 3 (2013) | THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS | Abstract similar documents |
| M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β ..." | ||
| Vol 8, No 6 (2012) | TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE | Abstract similar documents |
| O. D. Ostroumova, G. N. Shchukina, V. M. Fomina | ||
| Vol 5, No 4 (2009) | METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER | Abstract similar documents |
| B. N. Garifullin, A. N. Zakirova, F. S. Zarudij | ||
| "... Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI ..." | ||
| Vol 6, No 1 (2010) | AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... Author discusses antiatherosclerotic effects of dihydropyridine calcium channel blocker ..." | ||
| Vol 13, No 6 (2017) | THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| A. N. Zakirova, B. N. Garifullin, N. E. Zakirova | ||
| "... in experimental data. Carvedilol is a third-generation beta-blocker with additional pleiotropic and antioxidant ..." | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts ..." | ||
| Vol 6, No 5 (2010) | WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov | ||
| "... Aim. To determine indications for differential prescription of beta-blockers in patients ..." | ||
| Vol 9, No 4 (2013) | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... attention has recently been focused on the use of beta-blockers in the postoperative period. Nowadays ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..." | ||
| Vol 4, No 5 (2008) | CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... for comparable study of efficacy and safety of therapies based on β-blockers (carvedilol and metoprolol ..." | ||
| Vol 13, No 2 (2017) | ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE | Abstract similar documents |
| V. I. Podzolkov, N. A. Dragomiretskaya | ||
| "... conditions is studied well. The key role of aldosterone receptor blockers, particularly spironolactone ..." | ||
| Vol 18, No 5 (2022) | Comparative Pharmacoepidemiological Assessment of Antihypertensive Drugs Administration Structure in Pregnant Women in Routine Medical Practice in Kursk and Chisinau | Abstract similar documents |
| S. V. Povetkin, V. I. Gikavyj, N. G. Bachinski, O. V. Levashova, A. A. Kornilov, L. A. Podgurski, L. M. Tsurkan | ||
| "... in the group of calcium channel blockers belonged to short-acting nifedipine. Among beta-blockers in Kursk ..." | ||
| Vol 17, No 3 (2021) | Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome | Abstract similar documents |
| A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova | ||
| "... . A positive result of treatment depends on the severity of long QT syndrome and its genotype. Beta-blockers ..." | ||
| Vol 9, No 1 (2013) | THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE | Abstract similar documents |
| M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova | ||
| Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
| M. V. Leonova | ||
| "... Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented ..." | ||
| Vol 8, No 5 (2012) | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN | Abstract similar documents |
| R. I. Striuk, Ya. V. Brytkova | ||
| Vol 15, No 5 (2019) | Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris | Abstract similar documents |
| V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova | ||
| "... Aim. To evaluate the therapeutic efficacy of a combination of ivabradine and beta-blockers (BAB ..." | ||
| Vol 13, No 4 (2017) | PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW | Abstract similar documents |
| I. S. Yavelov | ||
| "... and safety of prolonged use of a combination of acetylsalicylic acid and blocker P2Y12 platelet receptor ..." | ||
| Vol 7, No 4 (2011) | SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION | Abstract similar documents |
| S. V. Nedogoda | ||
| "... Peculiarities of the treatment with angiotensin II receptor blocker telmisartan are analyzed ..." | ||
| Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
| I. M. Sokolov, N. A. Zheleznyakova | ||
| "... clinical trials. The triple combination of calcium antagonist, angiotensin II receptor blocker and thiazide ..." | ||
| Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... importance. The basis of AHT in diabetes and CKD is the combination of a blocker of the renin-angiotensin ..." | ||
| Vol 12, No 2 (2016) | ENDOTHELIAL DYSFUNCTION AND ROLE NITRATES AND BETA-BLOCKERS IN ITS CORRECTION IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. N. Britov | ||
| "... . The treating effect of some medicinal products (nitrates, beta-blockers and others) is analyzed from the point ..." | ||
| Vol 5, No 2 (2009) | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich | ||
| Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
| L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
| "... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... recommended for patients with a history of myocardial infarction (antiplatelets – 91.76%, beta-blockers – 83 ..." | ||
| Vol 7, No 3 (2011) | TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR | Abstract similar documents |
| I. M. Sokolov | ||
| "... medications that slow down HR: beta blockers (BB), If-channel inhibitors, nondihydropyridine calcium channel ..." | ||
| Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..." | ||
| Vol 10, No 4 (2014) | TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE | Abstract similar documents |
| O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov | ||
| Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
| A. V. Rodionov | ||
| Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
| O. M. Drapkina, E. I. Fomicheva | ||
| Vol 17, No 5 (2021) | Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use | Abstract similar documents |
| A. V. Matveev, E. A. Egorova, E. I. Konyaeva, A. G. Dormidor, E. Yu. Bekirova | ||
| "... that can lower the heart rate, beta-blockers (BAB) are still widely used in the pharmacotherapy ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... : selective thromboxane inhibitors, antagonists of thromboxane receptors, blockers of platelet receptors ..." | ||
| Vol 4, No 5 (2008) | CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| M. V. Soura | ||
| "... post MI angina attacks. Nowadays metoprolol is the only β-blocker having indication on secondary MI ..." | ||
| Vol 12, No 6 (2016) | CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE | Abstract similar documents |
| E. K. Shavarova, L. A. Babaeva, S. S. Padaryan, N. N. Soseliya, O. I. Lukina, A. S. Milto | ||
| "... receptor blockers (ARBs), of which only 23% in effective dose. β-blockers were prescribed in 41% of HFeEF ..." | ||
| Vol 13, No 6 (2017) | ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. Part 2. Antihypertensive and Organoprotective Effects of Amlodipine/Lisinopril Fixed-Dose Combination in Patients with Arterial Hypertension in the Presence of Overweight and Obesity | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchjonov, V. M. Fomina | ||
| "... mechanisms of the favorable impact of calcium channel blockers, as well as angiotensin-converting enzyme ..." | ||
| Vol 6, No 4 (2010) | CLOPIDOGREL PHARMACOGENETICS | Abstract similar documents |
| A. N. Meshkov | ||
| "... agents all over the world is clopidogrel, R2Y12-receptor blocker. It is shown that clopidogrel has ..." | ||
| 1 - 100 of 271 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
